Skip to main content
Caplight Logo









Real Endpoints

Real Endpoints

Private
Florham Park, New JerseyHealthcare & Life Scienceshttps://realendpoints.com/

Company Overview

Real Endpoints is a healthcare advisory and analytics company that provides market access solutions, reimbursement strategy, and AI-driven patient support tools for biopharmaceutical and medical device companies.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Revenue Cycle, Patient Engagement, Medical Devices, Compliance & Risk

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

market accessreimbursement strategyvalue-based contractingpatient assistancepatient affordabilityspecialty drug reimbursementhealthcare consultingpatient accesscopay assistancehub servicesmarket access consultingpayer analyticspharma commercializationpatient support programPSP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Real Endpoints Comparables

Compare Real Endpoints with similar companies based on industry and business-model similarity.

Real Endpoints comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Annexus Health
78%
TailorMed
76%
Lyfegen
76%

Real Endpoints Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Jeff Berkowitz

CEO

Executive Team

Real Endpoints Investors

Notable investors and investment history

Real Endpoints investors
InvestorRounds
A. M. Pappas & AssociatesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2025

    Monthly visitors increased 46% MoM.

  • Jul 8, 2024

    Grew 17% QoQ, from 18 to 21 employees.

Real Endpoints Filings

Explore SEC and related filing metadata, where available.

Real Endpoints filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Real Endpoints's valuation, stock price, and market status.

Is Real Endpoints a public or private company?

Real Endpoints is a private company.

What is the current stock price of Real Endpoints?

Real Endpoints is a private company with no public stock price. Caplight tracks Real Endpoints's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Real Endpoints worth (valuation)?

Valuation information for Real Endpoints is not publicly available.

Can I buy Real Endpoints stock?

Real Endpoints shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Real Endpoints's last funding round?

Funding round information for Real Endpoints is not publicly available.

Who are the main investors in Real Endpoints?

Key investors in Real Endpoints include A. M. Pappas & Associates.

Will Real Endpoints IPO soon?

No public IPO plans have been announced for Real Endpoints.

How can I track Real Endpoints secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Real Endpoints's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFlorham Park, New Jersey
Employee Range18
Year Founded2005
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?